Li et al. also observed 7 patients (2.3%) with serum ALT flare equal to or more than 400 IU/L among 306 patients with chronic hepatitis C, either during cancer chemotherapy or after 6 months of its cessation [68]. This evidence concerns the gene GPT and cancer.